Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

about

How I treat hepatitis C virus infection in patients with hematologic malignancies.

P2860

Q40604797-5559C658-3206-421D-B514-9474E3AB5385

P2860

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

Item

http://www.wikidata.org/entity/Q41678851

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

@en

type

Item

label

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

@en

prefLabel

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

@en

P1476

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

@en

P2093

C-H Wu

http://www.w3.org/2001/XMLSchema#string

C-S Chang

http://www.w3.org/2001/XMLSchema#string

H-C Wang

http://www.w3.org/2001/XMLSchema#string

H-H Hsiao

http://www.w3.org/2001/XMLSchema#string

H-J Tsai

http://www.w3.org/2001/XMLSchema#string

J-F Hsu

http://www.w3.org/2001/XMLSchema#string

M-L Yu

http://www.w3.org/2001/XMLSchema#string

S Y Hsiao

http://www.w3.org/2001/XMLSchema#string

S-F Lin

http://www.w3.org/2001/XMLSchema#string

T-C Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation.

Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.

Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.

Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

Long-term outcome of hepatitis C infection after bone marrow transplantation

P304

1003-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TID.12306

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shih-Feng Cho

P577

2014-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267762217

http://www.w3.org/2001/XMLSchema#string

P698

25367218

http://www.w3.org/2001/XMLSchema#string

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

about

P2860

P2860

Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698